Cargando…
The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine
BACKGROUND: Sigma-2 receptors are over-expressed in proliferating cancer cells, making an attractive target for the targeted treatment of pancreatic cancer. In this study, we investigated the role of the novel sigma-2 receptor ligand SW43 to induce apoptosis and augment standard chemotherapy. RESULT...
Autores principales: | Hornick, John R, Xu, Jinbin, Vangveravong, Suwanna, Tu, Zhude, Mitchem, Jonathan B, Spitzer, Dirk, Goedegebuure, Peter, Mach, Robert H, Hawkins, William G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106998/ https://www.ncbi.nlm.nih.gov/pubmed/21092190 http://dx.doi.org/10.1186/1476-4598-9-298 |
Ejemplares similares
-
Lysosomal Membrane Permeabilization is an Early Event in Sigma-2 Receptor Ligand Mediated Cell Death in Pancreatic Cancer
por: Hornick, John R, et al.
Publicado: (2012) -
The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer
por: Hashim, Yassar M., et al.
Publicado: (2017) -
Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancer
por: Garg, Gunjal, et al.
Publicado: (2014) -
Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma
por: Kashiwagi, Hiroyuki, et al.
Publicado: (2009) -
Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site
por: Xu, Jinbin, et al.
Publicado: (2011)